Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1979 Jan 1;177(1):347–352. doi: 10.1042/bj1770347

β-2-Thienyl-dl-alanine as an inhibitor of phenylalanine hydroxylase and phenylalanine intestinal transport

Raul A Wapnir 1, Gary S Moak 1
PMCID: PMC1186373  PMID: 570838

Abstract

The inhibitory properties of β-2-thienyl-dl-alanine on rat phenylalanine hydroxylase from crude liver and kidney homogenates were assessed in vitro and in vivo, as well as its effects on the intestinal transport of phenylalanine, by using a perfusion procedure in vivo. The apparent Km for liver phenylalanine hydroxylase changed from 0.61mm in the absence of the inhibitor to 2.70mm in the presence of 24mm-β-2-thienyl-dl-alanine, with no significant change in the Vmax.. For kidney the corresponding values were 0.50 and 1.60mm respectively. A single dose of β-2-thienyl-dl-alanine (2mmol/kg) failed to inhibit phenylalanine hydroxylase in either organ. Repeated injections during a 4-day period caused a decline of the enzymic activity to about 40% of controls. Intestinal absorption of phenylalanine when perfused at 0.2–2.0mm concentration was also competitively inhibited by β-2-thienyl-dl-alanine. Its Ki value was estimated at 81mm. The limited inhibitory effects of β-2-thienyl-dl-alanine towards hepatic phenylalanine hydroxylase and phenylalanine intestinal transport, and its rapid metabolism, as suggested by the small elimination of this compound in the urine and its virtual absence from animal tissues, are factors that restrict its potential usefulness as an inducer of phenylketonuria in rats or as an effective blocker of phenylalanine absorption by the gut.

Full text

PDF
347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayling J. E., Helfand G. D., Pirson W. D. Phenylalanine hydroxylase from human kidney. Enzyme. 1975;20(1):6–19. doi: 10.1159/000458915. [DOI] [PubMed] [Google Scholar]
  2. Ayling J. E., Pirson W. D., al-Janabi J. M., Helfand G. D. Kidney phenylalanine hydroxylase from man and rat. Comparison with the liver enzyme. Biochemistry. 1974 Jan 1;13(1):78–85. doi: 10.1021/bi00698a013. [DOI] [PubMed] [Google Scholar]
  3. Berry H. K., Cripps R., Nicholls K., McCandless D., Harper C. Development of phenylalanine hydroxylase activity in guinea pig liver. Biochim Biophys Acta. 1971 Feb 28;261(2):315–320. doi: 10.1016/0304-4165(72)90053-0. [DOI] [PubMed] [Google Scholar]
  4. Blackburn S. The determination of amino acids by high-voltage paper electrophoresis. Methods Biochem Anal. 1965;13:1–45. doi: 10.1002/9780470110317.ch1. [DOI] [PubMed] [Google Scholar]
  5. Counsell R. E., Desai P., Smith T. D., Chan P. S., Weinhold P. A., Rethy V. B., Burke D. Aromatic amino acid hydroxylase inhibitors. 1. Halogenated phenylalanines. J Med Chem. 1970 Nov;13(6):1040–1042. doi: 10.1021/jm00300a004. [DOI] [PubMed] [Google Scholar]
  6. DIXON M. The determination of enzyme inhibitor constants. Biochem J. 1953 Aug;55(1):170–171. doi: 10.1042/bj0550170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DeGraw J. I., Cory M., Skinner W. A., Theisen M. C., Mitoma C. Experimentally induced phenylketonuria. I. Inhibitors of phenylalanine hydroxylase. J Med Chem. 1967 Jan;10(1):64–66. doi: 10.1021/jm00313a013. [DOI] [PubMed] [Google Scholar]
  8. Godin C., Gajda A. T. The effect of phenylalanine analogues on the metabolism of tyrosine in rats. Can J Biochem. 1967 May;45(5):745–747. doi: 10.1139/o67-085. [DOI] [PubMed] [Google Scholar]
  9. Greengard O., Yoss M. S., Del Valle J. A. Alpha-methylphenylalanine, a new inducer of chronic hyperphenylalaninemia in sucling rats. Science. 1976 Jun 4;192(4243):1007–1008. doi: 10.1126/science.944951. [DOI] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Lines D. R., Waisman H. A. Renal amino acid reabsorption in hyperphenylalaninemic monkeys infused with beta-2-thienylalanine. Proc Soc Exp Biol Med. 1970 Sep;134(4):1061–1064. doi: 10.3181/00379727-134-34944. [DOI] [PubMed] [Google Scholar]
  12. Lines D. R., Waisman H. A. The inhibition of intestinal absorption of phenylalanine in the rhesus monkey. Proc Soc Exp Biol Med. 1970 Dec;135(3):859–863. doi: 10.3181/00379727-135-35159. [DOI] [PubMed] [Google Scholar]
  13. Lipton M. A., Gordon R., Guroff G., Udenfriend S. p-Chlorophenylalanine-induced chemical manifestations of phenylketonuria in rats. Science. 1967 Apr 14;156(3772):248–250. doi: 10.1126/science.156.3772.248. [DOI] [PubMed] [Google Scholar]
  14. McGee M. M., Greengard O., Knox W. E. The quantitative determination of phenylalanine hydroxylase in rat tissues. Its developmental formation in liver. Biochem J. 1972 May;127(4):669–674. doi: 10.1042/bj1270669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murthy L. I., Berry H. K. Development of phenylalanine hydroxylase activity in rat kidney. Arch Biochem Biophys. 1974 Jul;163(1):225–230. doi: 10.1016/0003-9861(74)90472-x. [DOI] [PubMed] [Google Scholar]
  16. Poncet I. B., Berry H. K., Butcher R. E., Kazmaier K. J. Biochemical effects of induced phenylketonuria in rats. Biol Neonate. 1975;26(1-2):88–101. doi: 10.1159/000240720. [DOI] [PubMed] [Google Scholar]
  17. Schultz S. G., Markscheid-Kaspi L. Competitive interactions between L-alanine and L-phenylalanine in rabbit ileum. Biochim Biophys Acta. 1971 Sep 14;241(3):857–860. doi: 10.1016/0005-2736(71)90013-7. [DOI] [PubMed] [Google Scholar]
  18. Valdivieso F., Gimenez C., Mayor F. In vivo inhibition of rat liver phenylalanine hydroxylase by p-chlorophenylalanine and Esculin. Experimental model of phenylketonuria. Biochem Med. 1975 Jan;12(1):72–78. doi: 10.1016/0006-2944(75)90097-6. [DOI] [PubMed] [Google Scholar]
  19. WONG P. W., O'FLYNN M. E., INOUYE T. MICROMETHODS FOR MEASURING PHENYLALANINE AND TYROSINE IN SERUM. Clin Chem. 1964 Dec;10:1098–1104. [PubMed] [Google Scholar]
  20. Wapnir R. A., Hawkins R. L., Lifshitz F. Hyperaminoacidemia effects on intestinal transport of related amino acids. Am J Physiol. 1972 Oct;223(4):788–793. doi: 10.1152/ajplegacy.1972.223.4.788. [DOI] [PubMed] [Google Scholar]
  21. Wapnir R. A., Hawkins R. L., Stevenson J. H., Bessman S. P. Effects of oral administration of p-chlorophenylalanine to experimental animals. Biochem Med. 1970 Apr;3(5):397–403. doi: 10.1016/0006-2944(70)90006-2. [DOI] [PubMed] [Google Scholar]
  22. Wapnir R. A., Lifshitz F. Inhibition of intestinal absorption of L-phenylalanine in vivo by l-Alanine. Proc Soc Exp Biol Med. 1976 Jul;152(3):307–311. doi: 10.3181/00379727-152-39385. [DOI] [PubMed] [Google Scholar]
  23. Wapnir R. A., Lifshitz F. L-phenylalanine interactions with structurally related substances at the intestinal mucosa. Biochem Med. 1974 Dec;11(4):370–375. doi: 10.1016/0006-2944(74)90136-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES